Program
Riboflavin
Also written as “riboflavin solution”, “Riboflavin 0.1% ophthalmic solution and pulsed light” and “Riboflavin 0.1% ophthalmic solution and non-pulsed light”.
Its studies are mostly in Keratoconus · Hyperopia · Dilatation, Pathologic · Corneal Ulcer · Fatigue, led by 4 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Glaukos | 50 open or running | phase 3since Apr 27, 2011 | Apr 27, 2011 | none ahead |
| Price Vision Group | 41 open or running | phase 3since Apr 17, 2019 | May 30, 2009 | Dec 31, 2030phase 3 · NCT07841470 |
| Nvision Laser Eye Centers | 10 open or running | phase 2since May 3, 2016 | May 3, 2016 | none ahead |
| Topcon | 10 open or running | phase 3since Jul 11, 2011 | Jul 11, 2011 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- May 30, 2009First study: no phase study in Corneal UlcerNew to Price Vision GroupPrice Vision Group · NCT00912509 · 30 enrolled · United States
- Jun 11, 2010Phase 2 study in KeratoconusPrice Vision Group · NCT01143389 · 510 enrolled · United States
- Apr 27, 2011Glaukos's first study: phase 3 study in KeratoconusNew to GlaukosGlaukos · NCT01344187 · 236 enrolled · United States
- Jul 11, 2011Topcon's first study: phase 3 study in KeratoconusNew to TopconTopcon · NCT01398852 · 500 enrolled · United States
- Jul 16, 20122 phase 3 studiesGlaukos · NCT01643252, NCT01643226
- Jun 28, 2013Phase 2 study in HyperopiaGlaukos · NCT01893359 · 2 enrolled · United States
- Oct 25, 2013Phase 3 study in KeratoconusGlaukos · NCT01972854 · 92 enrolled · United States
- May 3, 2016Nvision Laser Eye Centers's first study: phase 2 study in KeratoconusNew to Nvision Laser Eye CentersNvision Laser Eye Centers · NCT02762253 · 320 enrolled · United States
- Apr 17, 2019Phase 3 study in KeratoconusPrice Vision Group · NCT03922542 · 508 enrolled · United States
- Sep 19, 2026Phase 3 study in KeratoconusPrice Vision Group · NCT07841470 · 500 planned · United States
Ahead
- Dec 31, 2030Primary completion: phase 3 study in KeratoconusPrice Vision Group · NCT07841470
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 11 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07841470Keratoconus · United States | 3 | Recruiting | Price Vision Group | Dec 31, 2030 | 500 |
| NCT03922542Keratoconus · United States | 3 | Completed | Price Vision Group | Jun 30, 2026 | 508 |
| NCT02762253Keratoconus · United States | 2 | Terminated | Nvision Laser Eye Centers | Apr 2016 | 320 |
| NCT01972854Keratoconus · United States | 3 | Terminated | Glaukos | Mar 2016 | 92 |
| NCT01893359Hyperopia · United States | 2 | Terminated | Glaukos | Feb 2015 | 2 |
| NCT01643252Corneal Ectasia | 3 | Withdrawn | Glaukos | 0 | |
| NCT01643226Keratoconus · United States | 3 | Completed | Glaukos | Jul 2015 | 230 |
| NCT01398852Keratoconus · United States | 3 | Terminated | Topcon | Jul 2012 | 500 |
| NCT01344187Keratoconus · United States | 3 | Completed | Glaukos | Jun 2015 | 236 |
| NCT01143389Keratoconus · United States | 2 | Completed | Price Vision Group | May 30, 2017 | 510 |
| NCT00912509Corneal Ulcer · United States | – | Terminated | Price Vision Group | Jun 2013 | 30 |
How it is read
Names in the registry
- “riboflavin solution”, 3 entries
- “Riboflavin”, 2 entries
- “Riboflavin 0.1% ophthalmic solution and pulsed light”, 1 entry
- “Riboflavin 0.1% ophthalmic solution and non-pulsed light”, 1 entry
- “riboflavin 0.1%”, 1 entry
Conditions, from the studies’ own filings
- Keratoconus, 8 studies
- Hyperopia, 1 study
- Dilatation, Pathologic, 1 study
- Corneal Ulcer, 1 study
- Fatigue, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.